Avizia, the leading end to end telehealth solution provider, today announced the completion of its Series A financing totaling $17 million. The company raised an additional $6 million to supplement the initial $11 million, which was announced in July 2016. HealthQuest Capital led the additional round which included investment from strategic partner NewYork-Presbyterian.
Read MoreTrice Medical announced today that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for mi-eye 2, a disposable needle with a fully integrated camera that enables physicians to use advanced diagnostic imaging to visualize joint injuries in their clinic.
Read MoreMagnolia Medical Technologies, developer of the SteriPath® blood collection system and leader in improving the quality and accuracy of in-vitro diagnostic test results, today announced the closing of the company's $13.8 million Series B financing led by HealthQuest Capital. In conjunction with the financing, Garheng Kong, M.D., Ph.D., founder and managing partner of HealthQuest Capital will join the company's board.
Read MoreVirMedica, the leader in providing e-access and specialty pharmacy technology solutions designed to expedite patient access to biopharmaceutical products, today announced the appointment of three new executives to the Company's senior leadership team. John J. Arcari has been appointed to chief financial officer (CFO) and will oversee the Company's financial operations. Richard Deyermond joins the company as vice president of client services and will lead teams engaged in the delivery of VirMedica's technology solutions. As the vice president of engineering, Elizabeth Ricci will focus on building out the Company's technology suite.
Read MoreVirMedica, the leader in providing eACCESS technology solutions designed to expedite patient access to biopharmaceutical products, today announced that its Board of Directors has appointed Philip Lee as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately.
Read MoreTrice Medical, an early stage medical device company, announced the appointment of William Hawkins to the company's board of directors, effective April 1, 2016. Hawkins joins a distinguished Board of proven industry leaders in their pursuit to revolutionize arthroscopic diagnostics. Mr. Hawkins is a renowned healthcare executive with diverse experience in healthcare delivery, innovation, and entrepreneurship.
Read MoreHealthQuest Capital announced the closing of HealthQuest Capital II, LP, at the hard cap of $225 million and in excess of the initial fund target of $175 million. Investors in the fund include endowments, family offices, foundations, fund-of-funds, pension funds, and global healthcare organizations.
Read MoreSpirox Inc., a privately held medical device company, announced today the closing of a $45 million Series C round of financing led by KKR, a leading global investment firm. Also participating in the financing is new investor HealthQuest Capital along with major existing shareholders Aisling Capital, Aperture Venture Partners and Venrock.
Read MoreOrlando, Florida-based Vestagen Technical Textiles Inc, a medical technology company developing apparel for healthcare applications, raised $7 million in financing. Advent Life Sciences and HealthQuest Capital led the round, which was a planned extension of the company’s previous financing. Vestagen also named Bill Bold as chief executive officer. Bold replaces Dale Pfost, PhD, who was serving as interim CEO and remains chairman of the board.
Read More →
BioTheranostics, a leader in molecular diagnostics for cancer, today announced that it has closed a $32 million financing led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and HealthQuest Capital. As a result of the financing, bioTheranostics will be spun out from bioMérieux, which will remain a minority shareholder, and operate as an independent company.
Read More →
